• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail
-

Percentage of regulatory cases referred to OFS that were reviewed within the timeframe given to OFS in the Case Management System (measures time in OFS only) in the month

Dictionary: Timely review of regulatory cases that come from the field is important as it allows FDA to take appropriate regulatory action such as issuance of a warning letter to the regulated industry. This can lead to a timely correction of problems in the industry resulting in a safer food supply.

Information is current as of March 31, 2023.

Fiscal Year - 2023

Skip graphic and jump to text data

TimeTargetPercentage
Oct 2022N/A80
Nov 2022N/A78
Dec 2022N/A90
Jan 2023N/A93
Feb 2023N/A8
Mar 2023N/A33
Apr 2023N/ATBD
May 2023N/ATBD
Jun 2023N/ATBD
Jul 2023N/ATBD
Aug 2023N/ATBD
Sep 2023N/ATBD

FY 2023 YTD: 69%

Total number of regulatory cases referred to OFS that were reviewed within the timeframe given to OFS in the Case Management System (measures time in OFS only) in the month

Fiscal Year - 2023
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2022N/A12
Nov 2022N/A7
Dec 2022N/A18
Jan 2023N/A14
Feb 2023N/A1
Mar 2023N/A3
Apr 2023N/ATBD
May 2023N/ATBD
Jun 2023N/ATBD
Jul 2023N/ATBD
Aug 2023N/ATBD
Sep 2023N/ATBD

FY 2023 YTD: 55

Total number of regulatory cases referred to OFS in the month that are due within the month

Fiscal Year - 2023
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2022N/A15
Nov 2022N/A9
Dec 2022N/A20
Jan 2023N/A15
Feb 2023N/A12
Mar 2023N/A9
Apr 2023N/ATBD
May 2023N/ATBD
Jun 2023N/ATBD
Jul 2023N/ATBD
Aug 2023N/ATBD
Sep 2023N/ATBD

FY 2023 YTD: 80

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.

-
-